Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
about
Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysisEffects of oral contraceptives on selected parameters of the homeostatic control system in young women having a sudden disorder of the auditory and/or balance system.Combined hormonal contraception and venous thromboembolism.The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.[Venous thromboembolic disease in the region of Sidi Bel Abbes, Algeria: frequency and risk factors].Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.Toward a new concept of "natural balance" in oral estroprogestin contraception.Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.Sex hormone-binding globulin and thrombin generation in women using hormonal contraception.Venous thrombosis and oral contraceptives: current status.Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttal.Cyproterone acetate- and ethinyloestradiol-containing oral contraceptive as a risk factor for upper extremity deep venous thrombosis-a case report.Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors.
P2860
Q24624180-28E825FF-22F6-4159-BCE8-9DABA457DFC5Q30420494-D5431DC6-DF00-4942-9C71-326EC63ED7CAQ36845040-0151F78A-03DF-455A-8BA7-1ECE9420F3E0Q37305295-D0C5EC57-B1E8-4B11-B600-50292828AE6EQ37633798-DDFA6BC7-64ED-4B97-B5C7-347B81FB3A4CQ37975229-F306416C-95B4-4C52-89AA-14B13B56F49BQ38127769-83F32A8F-F7AA-42C4-B61D-547AE09A4E84Q38501601-D35BABFA-E89F-43B3-8DD3-6093AFA763A3Q39669514-60ED9822-31B5-46C6-9EC0-DBA61563CFCCQ43267080-3EA6C724-7D65-4AC0-A54F-C03412FAB099Q43603256-A92A884B-4DCC-4E6C-BF5A-30AF8465E373Q46064368-4D84D8EB-3884-4276-B8A7-8EAA14C82C36Q46366115-FC211B8F-6808-454E-83D2-AE1A5F957AE2Q50912748-750958CF-4A77-44AE-A7DB-942B92B44BE5
P2860
Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Association between sex hormon ...... aining different progestogens.
@en
Association between sex hormon ...... aining different progestogens.
@nl
type
label
Association between sex hormon ...... aining different progestogens.
@en
Association between sex hormon ...... aining different progestogens.
@nl
prefLabel
Association between sex hormon ...... aining different progestogens.
@en
Association between sex hormon ...... aining different progestogens.
@nl
P2093
P356
P1433
P1476
Association between sex hormon ...... aining different progestogens.
@en
P2093
Carine J M Doggen
Frans M Helmerhorst
Frits R Rosendaal
Huib A A M van Vliet
Jan Rosing
L G D Thomassen
M Christella
Marijke Frolich
P304
P356
10.1093/HUMREP/DEH612
P407
P577
2004-11-11T00:00:00Z